z-logo
open-access-imgOpen Access
[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
Author(s) -
Jia Liu,
Bingfei Dong,
Peisong Wang,
Peiyou Ren,
Shuai Xue,
Xiaonan Zhang,
Zhe Han,
Guang Chen
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8297
Subject(s) - in vivo , thyroid carcinoma , audience measurement , medicine , cancer research , oncogene , library science , oncology , cancer , biology , thyroid , political science , cell cycle , computer science , law , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom